United States Brain Market Insight
Published: 16 June 2026 | Report Format: Electronic (PDF)
The United States Brain Market is projected to grow at a CAGR of around 6.8%, driven by rising neurological disorder prevalence, increasing brain health awareness, advancements in neurodiagnostics, expanding neuroscience research, and growing investments in cognitive healthcare solutions.
United States Brain Market Forecasts to 2035
- The United States Brain Market Size Was Estimated at USD 68.25 Billion in 2025.
- The Market Size is Expected to Grow at a CAGR of around 6.8% from 2025 to 2035.
- The United States Brain Market Size is Expected to Reach around USD 131.80 Billion by 2035.
Notable Insights for the United States Brain Market
- Segmentation Based on Product Type, Neurodiagnostic Devices, Neurostimulation Devices, and Brain Monitoring Systems segments held a dominant position in the United States Brain Market in 2025 with nearly 79% share, driven by increasing neurological disease diagnosis and treatment demand.
- Segmentation Based on Application, Alzheimer's Disease, Parkinson's Disease, Epilepsy, and Cognitive Health Management segments collectively accounted for approximately 84% share in 2025, supported by expanding patient populations and advanced neurological care programs.
- The United States Brain Market is led by Medtronic, Johnson & Johnson, and GE HealthCare, with combined revenues exceeding USD 111.4 billion in 2025. Their strong neuroscience portfolios and neurotechnology investments continue strengthening market competitiveness.
- Rising adoption of AI-enabled neurodiagnostic platforms and advanced brain monitoring technologies is projected to improve diagnostic accuracy by nearly 24%, while personalized neurological therapies may enhance treatment outcomes by approximately 19% during the forecast period.
Download the eBook (ToC)
Why Buy This Report
- Provides a comprehensive analysis of the impact of neurological disease prevalence, brain health awareness, healthcare expenditure, and neuroscience research initiatives on market growth.
- Offers key insights into advancements in neuroimaging technologies, neurostimulation systems, AI-enabled diagnostics, cognitive health solutions, and precision neurology innovations.
- Helps stakeholders evaluate competitive positioning, investment opportunities, regulatory developments, technological innovations, and growth prospects of leading brain health and neuroscience market participants.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the United States brain market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in United States Brain Market
• Medtronic plc
• Johnson & Johnson MedTech
• GE HealthCare Technologies Inc.
• Siemens Healthineers AG
• Philips Healthcare
• Abbott Laboratories
• Boston Scientific Corporation
• NeuroPace, Inc.
• Ceribell, Inc.
• Natus Medical Incorporated
Recent Developments:
- In September 2025, NeuroPace, Inc. launched an enhanced responsive neurostimulation platform featuring advanced seizure detection algorithms designed to improve neurological disorder management and patient outcomes across specialized healthcare centers.
- In June 2025, GE HealthCare collaborated with Medtronic plc to integrate advanced neuroimaging and brain monitoring technologies, supporting precision neurology programs and improving clinical decision-making capabilities in the United States.
Market Segmentation:
United States Brain Market, By Product Type
• Neurodiagnostic Devices
• Neurostimulation Devices
• Brain Monitoring Systems
• Neuroimaging Systems
• Others
United States Brain Market, By Application
• Alzheimer's Disease
• Parkinson's Disease
• Epilepsy
• Traumatic Brain Injury
• Cognitive Health Management
• Others
United States Brain Market, By Technology
• AI-Based Brain Analytics
• Neuroimaging Technology
• Brain-Computer Interface
• Electrophysiology Systems
• Others
United States Brain Market, By End User
• Hospitals
• Neurology Clinics
• Research Institutes
• Diagnostic Centers
• Others
United States Brain Market, By Distribution Channel
• Direct Sales
• Medical Device Distributors
• Healthcare Procurement Networks
• Online Procurement Platforms
Expert Views:
The United States Brain Market is expected to witness robust growth through 2035, supported by increasing neurological disease burden, technological advancements in neurodiagnostics, and expanding investments in brain health research. Growing adoption of AI-driven neurological assessment tools, neurostimulation therapies, and precision medicine approaches is anticipated to accelerate market expansion. As healthcare providers continue prioritizing early diagnosis and personalized neurological care, the brain market will remain a critical segment of the United States healthcare ecosystem.